Day-to-day co-variations of psychological and physical symptoms of the menstrual cycle: Insights to individual differences in steroid reactivity

Psychoneuroendocrinology

Volumn 35, Issue 3, 2010, Pages 350-363

  Kiesner, Jeff ^a   Pastore, Massimiliano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Depression; Physical; Premenstrual; Somatic; Steroid; Symptoms

Indexed keywords

STEROID;

ABDOMINAL CRAMP; ANXIETY; ARTHRALGIA; ARTICLE; BACKACHE; BLOATING; COGNITION; DEPRESSION; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MENSTRUAL CYCLE; MENSTRUATION; MOOD CHANGE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUESTIONNAIRE; SKIN MANIFESTATION; SYMPTOMATOLOGY; TISSUE SPECIFICITY; UNIVERSITY STUDENT;

ADOLESCENT; ADULT; ARTHRALGIA; BREAST; CIRCADIAN RHYTHM; COLIC; FEMALE; GONADAL STEROID HORMONES; HEADACHE; HUMANS; INDIVIDUALITY; MENSTRUAL CYCLE; MENSTRUATION; QUESTIONNAIRES; SKIN; STRESS, PSYCHOLOGICAL; TIME FACTORS; YOUNG ADULT;

EID: 77649270891     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.07.011     Document Type: Article

References (45)

1. Ace C.I., Okulicz W.C. Differential gene regulation by estrogen and progesterone in the primate endometrium. Mol. Cell Endocrinol. 1995, 115:95-103.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
3. Asarian L., Geary N. Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-α-expressing cells in the nucleus tractus solitarius of ovariectomized rats. Endocrinology 2007, 148:5656-5666.
4. Bixo M., Andersson A., Winblad B., Purdy R.H., Bäckström T. Progesterone, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 1997, 764:173-178.
5. Bloch M., Schmidt P.J., Rubinow D.R. Premenstrual syndrome: evidence for symptom stability across cycles. Am. J. Psychiatry 1997, 154:1741-1746.
6. Bryk A.S., Raudenbush S.W. Hierarchical Linear Models: Application and Data Analysis Methods 1992, Sage Publications, Newbury Park.
7. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
8. Dawood Y.M. Primary dysmenorrhea: advances in pathogenesis and management. Obstet. Gynecol. 2006, 108:428-441.
9. Di Leo A., Barone M., Maiorano E., Tanzi S., Piscitelli D., Marangi S., Lofano K., Ierardi E., Principi M., Francavilla A. ER-β expression in large bowel adenomas: implications in colon carcinogenesis. Dig. Liver Dis. 2008, 40:260-266.
10. Doyle C., Swain Ewald H.A., Ewald P.W. Premenstrual syndrome: an evolutionary perspective on its causes and treatment. Perspect. Biol. Med. 2007, 50:181-202.
11. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:169-192.
12. Epperson C.N., Haga K., Mason G.F., Sellers E., Gueorguieva R., Zhang W., Weiss E., Rothman D.L., Krystal J.H. Cortical γ-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder. Arch. Gen. Psychiatry 2002, 59:851-858.
13. Freeman E.W. Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause. Dialogues Clin. Neurosci. 2002, 4:177-191.
14. Freeman E.W., DeRubeis R.J., Rickels K. Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res. 1996, 65:97-106.
15. Freeman E.W., Sondheimer S., Weinbaum P.J., Rickels K. Evaluating premenstrual symptoms in medical practice. Obstet. Gynecol. 1985, 65:500-505.
16. Gorodeski G.I. cGMP-dependent ADP depolymerization of actin mediates estrogen increase in cervical epithelial permeability. Am. J. Cell Physiol. 2000, 279:C2028-C2036.
17. Grandien K. Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol. Cell Endocrinol. 1996, 116:207-212.
18. Halbreich U., Borenstein J., Pearlstein T., Kahn L.S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003, 28:1-23.
19. Halbreich U., O'Brien S., Eriksson E., Bäckström T., Yonkers K.A., Freeman E.W. Are there differential symptom profiles that improve in response to different pharmacological treatments of Premenstrual Syndrome/Premenstrual Dysphoric Disorder?. CNS Drugs 2006, 20:523-547.
20. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., Drevets W.C. Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectrometry. Arch. Gen. Psychiatry 2007, 64:193-200.
21. Hikima T., Maibach H.I. Gender differences of enzymatic activity and distribution of 17β-hydroxysteroid dehydrogenase in human skin in vitro. Skin Pharmacol. Physiol. 2007, 20:168-174.
22. Howards P.P., Schisterman E.F., Wactawski-Wende J., Reschke J.E., Frazer A.A., Hovey K.M. Timing clinical visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle study. Am. J. Epidemil. 2009, 169:105-112.
23. Kelly R.W., King A.E., Critchley O.D. Cytokine control in human endometrium. Reproduction 2001, 121:3-19.
24. Kiesner J. Physical characteristics of the menstrual cycle and premenstrual depressive symptoms. Psychol. Sci. 2009, 20:763-770.
25. Kimbro S.K., Duschene K., Willard M., Moore J.A., Freeman S. A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment. Mol. Bio. Rep. 2008, 35:23-27.
26. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232:1004-1007.
27. Mannix L.K. Menstrual-related pain conditions: dysmenorrhea and migraine. J. Womens Health 2008, 5:879-891.
28. Martin V.T. New theories in pathologenesis of menstrual migraine. Curr. Pain Headache Rep. 2008, 12:453-462.
29. Norman R.J., Dewailly D., Legro R.S., Hickey T.E. Polycystic ovary syndrome. Lancet 2007, 370:685-697.
30. Oh H., Smart R.C. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:12525-12530.
31. Perlman W.R., Tomaskovic-Crook E., Montague D.M., Webster M.J., Rubinow D.R., Kleinman J.E., Weikert C.S. Alteration in estrogen receptor α mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biol. Psychiatry 2005, 58:812-824.
32. Puder J.J., Blum C.A., Mueller B., De Geyter C., Dye L., Keller U. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur. J. Clin. Invest. 2006, 36:58-64.
33. Rapkin A. A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder. Psychoneuroendocrinology 2003, 28:39-53.
34. Rubinow D.R., Hoban C.M., Grover G.N., Galloway S.D., Roy-Byrne P., Andersen R., Merriam G.R. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am. J. Obstet. Gynecol. 1988, 158:5-11.
35. Rubinow D.R., Schmidt P.J. Gonadal steroids, brain, and behavior: role of context. Dialogues Clin. Neurosci. 2002, 4:123-137.
36. Schechter D., Bachmann G.A., Vaitukaitis J., Phillips D., Saperstein D. Perimenstrual symptoms: time course of symptom intensity in relation to endocrinologically defined segments of the menstrual cycle. Psychosom. Med. 1989, 51:173-194.
37. Schmidt F., Grulich-Henn J., Heirich U.E., Bettendorf M. Mucosal cytology in the determination of the pubertal status in girls. Horm. Res. 2002, 58:223-228.
38. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Eng. J. Med. 1998, 338:209-216.
39. Steiner M., Macdougall M., Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch. Womens Ment. Health 2003, 6:203-209.
40. Strine T.W., Chapman D.P., Ahluwalia I.B. Menstrual-related problems and psychological distress among women in the United States. J. Womens Health 2005, 14:316-323.
41. Sunami E., Shinozaki M., Sim M.S., Nguyen S.L., Vu A.T., Giuliano A.E., Hoon D.S.B. Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Res. 2008, 10:R46.
42. Takeda T., Tasaka K., Sakata M., Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch. Womens Ment. Health 2006, 9:209-212.
43. Waeber C., Moskowitz M.A. Migraine as an inflammatory disorder. Neurology 2005, 64:S9-S15.
44. Williams M., Cunliffe W.J. Explanation for premenstrual acne. Lancet 1973, 302:1055-1057.
45. Wittchen H.U., Becker E., Lieb R., Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol. Med. 2002, 32:119-132.